COVID-19 (Coronavirus) Response
Last Updated April 5, 2022
The COVID-19 pandemic is rapidly evolving. Molina would like to share resources and updates with our provider partners.
-
Molina Healthcare of Texas Provider Resources & Notices
New Standard COVID-19 Vaccine Frequently Asked Questions
COVID-19 Vaccine Registration Notice
COVID-19 Prior Authorization Extensions
COVID-19 Provider Frequently Asked Questions
COVID-19 Provider Notification
COVID-19 – How to Prepare
COVID-19 – Interacting with Patients and Persons Under Investigation
Molina Healthcare COVID-19 Member Resources -
Telehealth/Telemedicine
Molina Healthcare of Texas COVID-19 Teletherapy Guidance
Claim Guidance for Telephone Behavioral Health Services
Claim Guidance for Telephone Medical Services
FQHC Reimbursement for Telemedicine (Physician Delivered) and Telehealth (Non-Physician Delivered Services)
Provider Identifier Usage for Telecommunication Services -
Texas Regulatory Resources and Notices
COVID-19 Update to Temporary Change to Home and Community-based Services, Texas Home Living Policy for Respite, Community First Choice Personal Assistance Service/Habilitation Services Providers
Guidance for FMSAs on Consumer Directed Services (CDS) Employer Orientations
New COVID-19 Diagnosis Codes and Inpatient ICD-10-PCS Procedure Codes Effective April 1, 2022
Telemedicine and Telehealth Services Provided by Rural Health Clinics
Multiple Medicaid COVID-19 Flexibilities Extended Through April 30, 2022 to Permanently Implement Rural Health Clinic Flexibility
COVID-19 Vaccine Administration Procedure Codes 0051A, 0052A, 0053A, and 0054A Are Now a Benefit
Updated Age Range for COVID-19 Vaccine Administration Procedure Code M0201
Reimbursement Rate Updates for COVID-19 Vaccine Administration Procedure Codes Effective January 3, 2022
COVID-19 Vaccine Administration Procedure Code 0073A is Now a Benefit
QW Modifier Required for COVID-19 Testing Procedure Code 86328
Monoclonal Antibody Administration Procedure Codes M0220 and M0221 for COVID-19 Now a Benefit
COVID-19 Vaccine Administration Procedure Code 0004A Now a Benefit for Individuals 12 or Older
COVID-19 Vaccine Administration Procedure Code 0004A is Now a Benefit for Individuals 16 Years Old or Older
Pfizer-BioNTech COVID-19 Booster Update
Merck Oral COVID-19 drug, Molnupiravir, Added to Formulary
Pfizer Oral COVID-19 Drug, Paxlovid, Added to Formulary
Updated COVID-19 Response Plan for Nursing Facilities
Pfizer-BioNTech COVID-19 Vaccine Booster Dose Age Change and New Formulation
CHIP Perinatal Members Eligible for COVID-19 Vaccine
Eligibility Changes for Pfizer-BioNTech and Moderna COVID-19 Vaccine Booster Doses
COVID-19 Vaccine Booster Update
Reimbursement Rate Updates for COVID-19 Vaccine Administration Procedure Codes 0071A and 0072A Effective October 29, 2021
Reimbursement Rate Updates for COVID-19 Vaccine Administration Procedure Codes 0034A and 0064A Effective October 20, 2021
Coverage of COVID-19 Booster Doses of Moderna and Johnson and Johnson Vaccines
Provider Enrollment Revalidation Extensions to End on February 28, 2022
Additional Diagnosis Code for Monoclonal Antibody Therapy Administration Codes M0245 and M0246
COVID-19 Guidance for New and Initial CSHCN Prior Authorizations
COVID-19 Guidance for New and Initial Medicaid Prior Authorizations
Medicaid DME Certification and Receipt Form COVID-19 Flexibility Extended Through December 31, 2021
COVID-19 Vaccine Administration Procedure Code 0004A is Now a Benefit
Medicaid COVID-19 Flexibility Extended Through October 31, 2021
CHIP Copayments Waived Through October 31, 2021
COVID-19 Update to Telehealth Guidance on CLASS Professional and Specialized Therapies
CSHCN COVID-19 Telehealth and Telemedicine Extensions Through December 31, 2021
Telemedicine (Physician Delivered) and Telehealth (Non-Physician Delivered) Extended Through December 31, 2021
Multiple Medicaid COVID-19 Flexibilities Extended Through December 31, 2021
COVID-19 Vaccine Administration Procedure Code M0201 Now a Benefit
Additional Diagnosis Code for Monoclonal Antibody Therapy Administration Code M0243
Getting COVID-19 Vaccines
COVID-19 Vaccine Administration Procedure Codes 0003A and 0013A Are Now Benefits
QW Modifier Required for COVID-19 Testing Procedure Code 87637
HHSC Publishes Requirements for Certain COVID-19 Flexibilities Expiring for CAS, PHC and FC Providers
Lifting of COVID-19 Statutory Suspensions
HHSC Extends TXHmL COVID-19 Emergency Rules through September 19, 2021
HHSC Publishes IL 2021-31 Guidance for FMSAs and CDS Employers due to COVID-19
Public Health Emergency Enrollment Application to be Discontinued Effective August 1, 2021
Multiple Medicaid COVID-19 Flexibilities Extended through July 31, 2021Best Practices for Temporary EVV Policies for Novel Coronavirus (COVID-19)
Home Health Agencies will be Reimbursed for COVID-19 Vaccine Administration Procedure Codes
Update to COVID-19 Guidance: Continuation of Benefit Request Extension to End June 30, 2021
QW Modifier Required for COVID-19 Testing Procedure Code 87636
Monoclonal Antibody Therapy Codes M0239 and Q0239 No Longer Benefits - Effective April 30, 2021
End of COVID-19 MDS Authorization Extensions for Nursing Facility Providers
COVID-19 Guidance for New and Initial CSHCN Prior Authorizations
Some COVID-19 Laboratory Procedure Codes Updated to Become Benefits for Pharmacists and Pharmacy ProvidersFQHCs and RHCs Reimbursement for COVID-19 Vaccine Administration Services
Monoclonal Antibody Therapy Procedure Codes Q0245 and M0245 Approved for COVID-19 Treatment
COVID-19 Vaccination Hub Providers
COVID-19 Vaccine Coverage includes Moderna
COVID-19 Vaccination Provider Enrollment
COVID-19 Vaccine Provider Questions
Texas Vendor Drug Program - COVID-19 Vaccine
COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers
COVID-19 Vaccine Administration Procedure Codes 0001A and 0002A are now Benefits - December 14, 2020
Existing EVV Users: Temporary EVV Policies for COVID-19 to End December 31, 2020
Existing EVV Users: Temporary EVV Policies for COVID-19 Extended to November 30, 2020
Texas Health Steps Telemedicine Guidance for Providers: Answers to Common Questions
Texas Health Steps (THSteps) Medical Checkups via Remote Delivery During Implementation of COVID-19 Restrictions
Coronavirus Aid, Relief, and Economic Security (CARES) Information
Reimbursement Rate Updates for Procedure Code C9803 - Effective March 1, 2020
Coronavirus Testing Procedure Codes to Become Benefit -
Medicare/MMP COVID-19 Provider Notices
Medicare & MMP Extend 2% Sequester Reduction - April 15, 2021
Temporary Claims Hold Pending Congressional Action to Extend 2% Sequester Reduction Suspension
CMS COVID-19 Provider Bulletin - December 15, 2020
CMS COVID-19 Provider Bulletin - May 18, 2020
CMS COVID-19 Provider Bulletin – May 4, 2020
CMS COVID-19 Provider Bulletin – April 30, 2020
CMS COVID-19 Provider Bulletin – April 29, 2020
CMS COVID-19 Provider Bulletin – April 28, 2020
CMS COVID-19 Provider Bulletin – April 14, 2020
CMS COVID-19 Provider Bulletin – April 9, 2020 - Behavioral Health
- Additional Resources